{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:42:10Z","timestamp":1751244130135,"version":"3.40.5"},"reference-count":32,"publisher":"Cambridge University Press (CUP)","issue":"12","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S1047951121005072_as1\"><jats:title>Objective:<\/jats:title><jats:p>To determine the efficacy and safety of endotracheal instillation of iloprost as a rescue therapy for persistent pulmonary hypertension of the newborn.<\/jats:p><\/jats:sec><jats:sec id=\"S1047951121005072_as2\"><jats:title>Methods:<\/jats:title><jats:p>Neonates diagnosed with persistent pulmonary hypertension who were unresponsive to standard treatment protocol applied for persistent pulmonary hypertension in our unit, and who were being followed up with mechanical ventilation, were included in the study. Iloprost was instilled endotracheally as a rescue treatment. Systolic pulmonary artery pressure, oxygen saturation index, mean airway pressure, fraction of inspired oxygen, preductal and postductal venous oxygen saturation, heart rate, and blood pressure were recorded before and after 30 minutes of endotracheal iloprost instillation. Adverse events after endotracheal iloprost were recorded.<\/jats:p><\/jats:sec><jats:sec id=\"S1047951121005072_as3\"><jats:title>Results:<\/jats:title><jats:p>Twenty neonates were included. The median gestational age and birth weight were found to be 37 (30.5-38) weeks and 2975 (2125-3437.5) grams, respectively. When compared to the period before endotracheal iloprost instillation, systolic pulmonary artery pressure, oxygen saturation index, mean airway pressure, and fraction of inspired oxygen values significantly decreased (p &lt; 0.001, p &lt; 0.001, p = 0.021, p = 0.001, respectively), whereas preductal and postductal oxygen saturation values significantly increased 30 minutes after the endotracheal iloprost instillation (p = 0.002, p &lt; 0.001, respectively). There were no significant differences in heart rate and blood pressure values before and after the iloprost administration. No adverse events were observed.<\/jats:p><\/jats:sec><jats:sec id=\"S1047951121005072_as4\"><jats:title>Conclusion:<\/jats:title><jats:p>Endotracheal instillation of iloprost was found to be an effective and safe therapy for persistent pulmonary hypertension unresponsive to conventional treatment.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s1047951121005072","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T06:21:13Z","timestamp":1641450073000},"page":"1894-1900","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of endotracheal instillation of iloprost for persistent pulmonary hypertension of the newborn"],"prefix":"10.1017","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-0648","authenticated-orcid":false,"given":"Asli","family":"Okbay Gunes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6512-6868","authenticated-orcid":false,"given":"Murat","family":"Ciftel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Emcet","family":"Timur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceren","family":"Dedebali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betul Zehra","family":"Pirdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"S1047951121005072_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2016.09.011"},{"key":"S1047951121005072_ref9","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.129849"},{"key":"S1047951121005072_ref16","first-page":"926968","article-title":"PGI2 as a regulator of inflammatory diseases","author":"Dorris","year":"2012; 2012:","journal-title":"Mediat Inflamm"},{"key":"S1047951121005072_ref18","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.12040932"},{"key":"S1047951121005072_ref20","first-page":"63","article-title":"Persistent pulmonary hypertension in the newborn","volume":"4","author":"Mathew","year":"2017","journal-title":"Children (Basel)"},{"key":"S1047951121005072_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4160-3640-1.50039-3"},{"key":"S1047951121005072_ref31","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1348949"},{"key":"S1047951121005072_ref5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00097107"},{"key":"S1047951121005072_ref8","doi-asserted-by":"publisher","DOI":"10.1253\/circj.71.1785"},{"key":"S1047951121005072_ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9592.2006.02104.x"},{"key":"S1047951121005072_ref30","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22985"},{"key":"S1047951121005072_ref28","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.03927"},{"key":"S1047951121005072_ref24","first-page":"CD005494","article-title":"Sildenafil for pulmonary hypertension in neonates","volume":"8","author":"Kelly","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"S1047951121005072_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(93)90431-J"},{"key":"S1047951121005072_ref29","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-984370"},{"key":"S1047951121005072_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.09.025"},{"key":"S1047951121005072_ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.1179"},{"key":"S1047951121005072_ref15","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e3181d10845"},{"key":"S1047951121005072_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2017.03.004"},{"key":"S1047951121005072_ref19","doi-asserted-by":"publisher","DOI":"10.5152\/TurkPediatriArs.2018.01810"},{"key":"S1047951121005072_ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-013-0263-1"},{"key":"S1047951121005072_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.04.005"},{"key":"S1047951121005072_ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000499361"},{"key":"S1047951121005072_ref2","first-page":"CD012963","article-title":"Prostanoids and their analogues for the treatment of pulmonary hypertension in neonates","volume":"10","author":"Shivanna","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"S1047951121005072_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80377-4"},{"key":"S1047951121005072_ref32","first-page":"388","article-title":"Inhaled iloprost in the treatment of pulmonary hypertension in very low birth weight infants: a report of two cases","volume":"62","author":"Gokce","year":"2012","journal-title":"J Pak Med Assoc"},{"key":"S1047951121005072_ref25","first-page":"235","article-title":"Effects of inhaled iloprost for the management of persistent pulmonary hypertension of the newborn","volume":"150","author":"Verma","year":"2021","journal-title":"Am J Perinatol"},{"key":"S1047951121005072_ref3","first-page":"CD000509","article-title":"Inhaled nitric oxide for respiratory failure in preterm infants","volume":"1","author":"Barrington","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"S1047951121005072_ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-021-04138-4"},{"key":"S1047951121005072_ref13","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903164228"},{"key":"S1047951121005072_ref10","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951103000726"},{"key":"S1047951121005072_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.09.031"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951121005072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T08:19:55Z","timestamp":1684743595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951121005072\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1047951121005072"],"URL":"https:\/\/doi.org\/10.1017\/s1047951121005072","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"type":"print","value":"1047-9511"},{"type":"electronic","value":"1467-1107"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"\u00a9 The Author(s), 2022. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}